Comparison of Multiple Allergen Simultaneous Tests: Advansure AlloScreen Max 108 and Protia Allergy-Q 128M
Clinical Laboratory · 2025
DOI: 10.7754/clin.lab.2024.241127 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Clinical Laboratory, 2025. Verfasst von Chi-Hun Lee und 7 weiteren Autor:innen. Hauptthemen laut MEDLINE: Allergens, Hypersensitivity. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
BACKGROUND: Multiple allergen simultaneous test (MAST) is a convenient, cost-effective, semi-quantitative immunoassay widely used for allergy screening. However, cross-reactions, such as those caused by IgE against Bet v 1 or cross-reactive carbohydrate determinants, should be considered when interpreting MAST results. This study aimed to compare two MASTs, Advansure AlloScreen Max108 (AlloScreen assay; LG Chem Ltd., Seoul, Korea) and PROTIA Allergy-Q 128M (Allergy-Q assay; ProteomeTech Inc., Seoul, Korea). METHODS: A total of 89 serum samples (56 positive and 33 negative) were analyzed through AlloScreen and Allergy-Q assays for 104 common allergens. Discrepant results were confirmed using the ImmunoCAP assay (Phadia AB, Uppsala, Sweden). In addition, concomitant sIgE reactivity to plant-derived food allergens related to Bet v 1 was assessed in birch pollen-positive samples. RESULTS: The total agreement between the two MASTs was 94.4% (kappa = 0.661), and class consistency was 0.878 (p < 0.001). Among the 78 discrepancies assessable by ImmunoCAP, Allergy-Q showed an agreement of 51.3%, while AlloScreen showed 48.7%. In birch pollen-positive samples, Allergy-Q demonstrated a higher positivity for concomitant sIgE reactions to plant-derived food allergens (46.9%) compared to AlloScreen (23.4%). CONCLUSIONS: The AlloScreen and Allergy-Q assays showed good overall agreement and class consistency. However, differences were observed in their detection of concomitant sIgE reactivity to plant-derived food allergens in birch pollen-positive samples. Further studies, incorporating clinical symptom evaluation, are needed to establish the clinical utility and reliability of these assays.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Lee, C. H., Park, M. S., Kim, J. A., Moon, S., Cho, E. H., Kwon, M. J., Park, H., & Woo, H. Y. (2025). Comparison of Multiple Allergen Simultaneous Tests: Advansure AlloScreen Max 108 and Protia Allergy-Q 128M. Clinical Laboratory. https://doi.org/10.7754/clin.lab.2024.241127
Vancouver
Lee CH, Park MS, Kim JA, Moon S, Cho EH, Kwon MJ, et al. Comparison of Multiple Allergen Simultaneous Tests: Advansure AlloScreen Max 108 and Protia Allergy-Q 128M. Clinical Laboratory. 2025. doi:10.7754/clin.lab.2024.241127
BibTeX
@article{Lee2025,
author = {Lee, Chi-Hun and Park, Min-Seung and Kim, Jee Ah and Moon, Suhyeon and Cho, Eun Hye and Kwon, Min-Jung and Park, Hyosoon and Woo, Hee-Yeon},
title = {Comparison of Multiple Allergen Simultaneous Tests: Advansure AlloScreen Max 108 and Protia Allergy-Q 128M},
journal = {Clinical Laboratory},
year = {2025},
doi = {10.7754/clin.lab.2024.241127}
}
EUVIMED